Adaptiiv Cleared to Market 3D Bolus Software

The FDA granted 510(k) clearance for Adaptiiv’s 3D bolus software, allowing the company to market the 3D printing software in the U.S.

The software is used to create 3D customized personal medical devices, primarily for the treatment of cancer.

The patient-specific devices can be used during radiation treatment to address issues practitioners face, such as air gaps in bolus and sparing healthy tissues during electron treatments.